In liver cancer and breast cancer, FTO promotes tumor progression by regulating the m6A level of oncogenes [22, 23], but its role in osteosarcoma and the upstream and downstream regulatory network remains unclear. The gene discussed is FTO; the disease is breast carcinoma.